Haatch Delivers Third Fund Exit in Three Months: CareLineLive

By
Jessica Fox
By
Haatch

We’re pleased to announce the exit of CareLineLive from the Haatch portfolio, marking our third exit in just three months. It is a strong testament to the strength of the Haatch portfolio and our commitment to delivering investor returns.

Delivering three exits in three months isn’t luck. It reflects our commitment to backing visionary founders and validates the investment strategy we’ve built at Haatch.

CareLineLive, a leading all-in-one home care management platform, has secured a majority investment by Accel-KKR, a top-tier global technology investment firm. The transaction provides significant follow-on funding from Accel-KKR to support the next stage of CareLineLive’s growth, with a focus on innovation, geographic expansion, and customer success.

Haatch was proud to support CareLineLive through its growth journey, from product development and commercial traction to international expansion. This transaction is a strong validation of the team’s impact in transforming home care services across the UK and beyond.

Our focus remains clear - delivering exceptional returns through high-quality early-stage investments. This latest exit is another step in that journey. Here’s to more wins ahead!

By
Jessica Fox
Head of Investor Relations
News & Updates

The latest
‍from Haatch

See More

The AI apocalypse is happening upstairs. We work downstairs.

By
Jonathan Keeling
By
Haatch
November 6, 2026
Read more
​

AI is either about to crash the stock market or put every software company out of business, depending on the headline. Haatch Partner Jeremy Luzinda pulls the two apocalypse stories apart and explains why the drama is upstairs, while the work is down here.

​

Crediflow AI raises £1.5m to scale AI-native infrastructure for commercial credit

By
Jordan Smith
By
Haatch
November 4, 2026
Read more
​

Haatch portfolio company Crediflow AI has secured £1.5m in a round led by PXN Ventures via NPIF II, with participation from Haatch and angel investors, to automate the manual work that slows down commercial lending.

​

Virtual Science AI launches Medical Competitor AI

By
Jordan Smith
By
Haatch
October 26, 2026
Read more
​

Haatch portfolio company Virtual Science AI has launched Medical Competitor AI, its fourth product, bringing real-time competitive intelligence to pharma medical affairs teams.

​

Judged by our returns, not our size

By
Jonathan Keeling
By
Haatch
October 12, 2026
Read more
​

Why Haatch built a business beyond fundraising for fees, and why that matters for investor returns.

​